Cargando…
Chemically modified mRNA beyond COVID-19: Potential preventive and therapeutic applications for targeting chronic diseases
Chemically modified mRNA represents a unique, efficient, and straightforward approach to produce a class of biopharmaceutical agents. It has been already approved as a vaccination-based method for targeting SARS-CoV-2 virus. The COVID-19 pandemic has highlighted the prospect of synthetic modified mR...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552589/ https://www.ncbi.nlm.nih.gov/pubmed/34915673 http://dx.doi.org/10.1016/j.biopha.2021.112385 |
_version_ | 1784591407748481024 |
---|---|
author | Elkhalifa, Dana Rayan, Menatallah Negmeldin, Ahmed T. Elhissi, Abdelbary Khalil, Ashraf |
author_facet | Elkhalifa, Dana Rayan, Menatallah Negmeldin, Ahmed T. Elhissi, Abdelbary Khalil, Ashraf |
author_sort | Elkhalifa, Dana |
collection | PubMed |
description | Chemically modified mRNA represents a unique, efficient, and straightforward approach to produce a class of biopharmaceutical agents. It has been already approved as a vaccination-based method for targeting SARS-CoV-2 virus. The COVID-19 pandemic has highlighted the prospect of synthetic modified mRNA to efficiently and safely combat various diseases. Recently, various optimization advances have been adopted to overcome the limitations associated with conventional gene therapeutics leading to wide-ranging applications in different disease conditions. This review sheds light on emerging directions of chemically modified mRNAs to prevent and treat widespread chronic diseases, including metabolic disorders, cancer vaccination and immunotherapy, musculoskeletal disorders, respiratory conditions, cardiovascular diseases, and liver diseases. |
format | Online Article Text |
id | pubmed-8552589 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Authors. Published by Elsevier Masson SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85525892021-10-29 Chemically modified mRNA beyond COVID-19: Potential preventive and therapeutic applications for targeting chronic diseases Elkhalifa, Dana Rayan, Menatallah Negmeldin, Ahmed T. Elhissi, Abdelbary Khalil, Ashraf Biomed Pharmacother Review Chemically modified mRNA represents a unique, efficient, and straightforward approach to produce a class of biopharmaceutical agents. It has been already approved as a vaccination-based method for targeting SARS-CoV-2 virus. The COVID-19 pandemic has highlighted the prospect of synthetic modified mRNA to efficiently and safely combat various diseases. Recently, various optimization advances have been adopted to overcome the limitations associated with conventional gene therapeutics leading to wide-ranging applications in different disease conditions. This review sheds light on emerging directions of chemically modified mRNAs to prevent and treat widespread chronic diseases, including metabolic disorders, cancer vaccination and immunotherapy, musculoskeletal disorders, respiratory conditions, cardiovascular diseases, and liver diseases. The Authors. Published by Elsevier Masson SAS. 2022-01 2021-10-28 /pmc/articles/PMC8552589/ /pubmed/34915673 http://dx.doi.org/10.1016/j.biopha.2021.112385 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review Elkhalifa, Dana Rayan, Menatallah Negmeldin, Ahmed T. Elhissi, Abdelbary Khalil, Ashraf Chemically modified mRNA beyond COVID-19: Potential preventive and therapeutic applications for targeting chronic diseases |
title | Chemically modified mRNA beyond COVID-19: Potential preventive and therapeutic applications for targeting chronic diseases |
title_full | Chemically modified mRNA beyond COVID-19: Potential preventive and therapeutic applications for targeting chronic diseases |
title_fullStr | Chemically modified mRNA beyond COVID-19: Potential preventive and therapeutic applications for targeting chronic diseases |
title_full_unstemmed | Chemically modified mRNA beyond COVID-19: Potential preventive and therapeutic applications for targeting chronic diseases |
title_short | Chemically modified mRNA beyond COVID-19: Potential preventive and therapeutic applications for targeting chronic diseases |
title_sort | chemically modified mrna beyond covid-19: potential preventive and therapeutic applications for targeting chronic diseases |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552589/ https://www.ncbi.nlm.nih.gov/pubmed/34915673 http://dx.doi.org/10.1016/j.biopha.2021.112385 |
work_keys_str_mv | AT elkhalifadana chemicallymodifiedmrnabeyondcovid19potentialpreventiveandtherapeuticapplicationsfortargetingchronicdiseases AT rayanmenatallah chemicallymodifiedmrnabeyondcovid19potentialpreventiveandtherapeuticapplicationsfortargetingchronicdiseases AT negmeldinahmedt chemicallymodifiedmrnabeyondcovid19potentialpreventiveandtherapeuticapplicationsfortargetingchronicdiseases AT elhissiabdelbary chemicallymodifiedmrnabeyondcovid19potentialpreventiveandtherapeuticapplicationsfortargetingchronicdiseases AT khalilashraf chemicallymodifiedmrnabeyondcovid19potentialpreventiveandtherapeuticapplicationsfortargetingchronicdiseases |